Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,070.27, with a market capitalization of 1.01T. The stock trades at a price-to-earnings (P/E) ratio of 52.27 and offers a dividend yield of 56.8%.
As of 2025-12-19, Eli Lilly(LLY) stock has fluctuated between $1,056.00 and $1,075.38. The current price stands at $1,070.27, placing the stock +1.4% above today's low and -0.5% off the high.
Eli Lilly(LLY) shares are trading with a volume of 5.77M, against a daily average of 3.52M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
Eli Lilly’s New Pill Keeps the Weight Off Eli Lilly said its experimental daily obesity pill helped patients maintain most of their weight loss after switching...
Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Twin Momentum Investor m...
Analyst Jason Gerberry of Bank of America Securities reiterated a Buy rating on Eli Lilly & Co, retaining the price target of $1,268.00. Claim 50% Off TipRanks...
Analyst ratings
77%
of 31 ratingsMore LLY News
These industry titans have gone in opposite directions this year; is that likely to change? UnitedHealth Group (UNH 0.97%) and Eli Lilly (LLY +1.38%) are two o...
Key Points Invest in stocks with good fundamentals, solid growth prospects, and steady dividends. These blue chip stocks have strong businesses that generate...
Biotech and Pharma Lose Weight on Zepbound, Keep It Off With Eli Lilly’s New Pill? Data Say That Works. In this article NOVO.B LLY Eli Lilly has a new pill, cal...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund l...
H.C. Wainwright notes that this morning, Eli Lilly (LLY) announced positive topline results from the Phase 3 ATTAIN-MAINTAIN trial, which the firm believes repr...
U.S. pharmaceutical company Eli Lilly & Co. (LLY) says that its new obesity pill helped patients maintain the majority of their weight loss after they switched...
Eli Lilly recently reported strong Phase 3 results for its next-generation obesity drugs, including the oral GLP‑1 pill orforglipron for weight maintenance and...
